GlassScriptPhysician profile
Farhan Siddiqui
NPI 1598754301
$576.71
in general payments reported to CMS, 2019-2025
16 companies · $63.35 in 2025
The $63.35 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $221 · 2020: $79.06 · 2021: $13.29 · 2022: $54.15 · 2024: $146 · 2025: $63.35.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $209.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $209.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sunovion Pharmaceuticals INC. | $119.90 | 2019-2020 | |
| Melinta Therapeutics, LLC | $68.14 | 2024-2025 | Rezzayo, Orbactiv, Kimyrsa |
| Cumberland Pharmaceuticals, INC. | $55.17 | 2020-2021 | |
| Janssen Pharmaceuticals, INC | $46.85 | 2019 | |
| Kerecis Limited | $45.99 | 2024-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
| Actelion Pharmaceuticals US, INC. | $41.52 | 2019 | |
| Glaxosmithkline, LLC. | $28.61 | 2024 | Nucala |
| Gilead Sciences, INC. | $26.13 | 2019 | |
| Alexion Pharmaceuticals, INC. | $25.82 | 2024 | Ultomiris |
| Abbvie INC. | $24.69 | 2024 | |
| Shionogi INC | $24.60 | 2022 | |
| Grifols USA, LLC | $17.77 | 2022 | |
| Smith+Nephew, INC. | $16.19 | 2024 | Collagenase Santyl |
| Convatec INC. | $12.09 | 2020 | |
| Reddress USA, INC. | $11.78 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo Pharmaceuticals INC. | $11.46 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Farhan Siddiqui listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.